Anti-CD20 monoclonal antibodies
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anti-CD20 monoclonal antibodies, covering 2018-05-04 to 2025-03-25. Get the full timeline:
Most recent: Clinical Trial Update: Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies [Phase 2]